A passive immunotherapy, (PE)HRG214, in patients infected with human immunodeficiency virus: a phase I study.
Dezube BJ, Proper J, Zhang J, Choy VJ, Weeden W, Morrissey J, Burns EM, Dixon JD, O'Loughlin C, Williams LA, Pickering PJ, Crumpacker CS, Gelder FB.
Dezube BJ, et al.
J Infect Dis. 2003 Feb 1;187(3):500-3. doi: 10.1086/367710. Epub 2003 Jan 8.
J Infect Dis. 2003.
PMID: 12552435
Clinical Trial.